| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―May―04 |
Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach |
Noor Atatreh, Lana Bustanji, Juliana Ferreira, Wael Rabeh, Radwa Mahgoub, Mohammad Ghattas |
| 2 |
[GO] |
2025―Aug―26 |
Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects |
Duo Lv, Sichan Li, Yi Li, Meihua Lin, You Zhai, Meijia Wu, Yunqing Qiu, Qingwei Zhao, Jian Liu |
| 3 |
[GO] |
2025―Jun―09 |
Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients |
Ruanjuan Zhan, Yuxin Shen, Haoxin Fu, Hualu Wu, Xiaohai Chen, Yige Yu, Ren-Ai Xu |
| 4 |
[GO] |
2025―May―15 |
Design and Evaluation of Andrographolide Analogues as SARS-CoV-2 Main Protease Inhibitors: Molecular Modeling and in vitro Studies |
Utid Suriya, Pansachon Intamalee, Rungnapha Saeeng, Patcharin Wilasluck, Peerapon Deetanya, Kittikhun Wangkanont, Phongthon Kanjanasirirat, Chanikarn Wongwitayasombat, Bodee Nutho |
| 5 |
[GO] |
2024―Dec―02 |
Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection |
Runcong Zhang, Jing Fan, Lu Han, Juehui Mao, Liang Sun, Yuetian Yu, Weibin Fan, Jiao Xie, Bin Lin, Nengming Lin |
| 6 |
[GO] |
2024―Sep―20 |
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches |
Ali Attiq, Sheryar Afzal, Habibah Wahab, Waqas Ahmad, Mahmoud Kandeel, Yassir Almofti, Ahmed Alameen, Yuan Seng Wu |
| 7 |
[GO] |
2024―May―29 |
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination |
Leonidas Panos, Panagiotis Bargiotas, Georgios Hadjigeorgiou, Georgios Panos |
| 8 |
[GO] |
2023―Jan―19 |
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19 |
Shih-Lung Cheng, Ping-Huai Wang, Cheng-Yu Chang, Hsu-Hui Wang, Chung-Jen Wang, Kuan-Ming Chiu |
| 9 |
[GO] |
2022―Oct―18 |
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study |
Vincenzo Spagnuolo, Marta Voarino, Marco Tonelli, Laura Galli, Andrea Poli, Elena Bruzzesi, Sara Racca, Nicola Clementi, Chiara Oltolini, Moreno Tresoldi, Patrizia Rovere Querini, Lorenzo Dagna, Alberto Zangrillo, Fabio Ciceri, Massimo Clementi, Antonella Castagna |
| 10 |
[GO] |
2022―Sep―08 |
Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach |
Heba Abdel-Halim, Malak Hajar, Luma Hasouneh, Suzanne M A Abdelmalek |
| 11 |
[GO] |
2022―Aug―02 |
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents |
Lara Alzyoud, Mohammad A Ghattas, Noor Atatreh |
| 12 |
[GO] |
2022―Jul―11 |
Recent Progress in the Development of Opaganib for the Treatment of Covid-19 |
Charles D Smith, Lynn W Maines, Staci N Keller, Vered Katz Ben-Yair, Reza Fathi, Terry F Plasse, Mark L Levitt |
| 13 |
[GO] |
2022―Apr―08 |
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds |
Jiajie Zhu, Haiyan Zhang, Qinghong Lin, Jingting Lyu, Lu Lu, Hanxi Chen, Xuning Zhang, Yanjun Zhang, Keda Chen |
| 14 |
[GO] |
2022―Mar―30 |
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19? |
Xuesong He, Xiao Xue Zeng |
| 15 |
[GO] |
2022―Mar―24 |
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir |
Santiago Moreno, Bernardino Alcázar-Navarrete, Carlos Dueñas, Juan González del Castillo, Julián Olalla, Antonio Antela |
| 16 |
[GO] |
2022―Mar―14 |
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval |
Nada A Ashour, Ayman Abo Elmaaty, Amany A Sarhan, Eslam B Elkaeed, Ahmed M Moussa, Ibrahim Ali Erfan, Ahmed A Al-Karmalawy |
| 17 |
[GO] |
2021―Oct―27 |
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection |
Sabrina Bimonte, Cira Antonietta Forte, Massimiliano Cuomo, Gennaro Esposito, Marco Cascella, Arturo Cuomo |
| 18 |
[GO] |
2021―Aug―25 |
Role of Folate, Cobalamin, and Probiotics in COVID-19 Disease Management [Letter] |
Dayab Asad, Syed Hasan Shuja |
| 19 |
[GO] |
2021―Jul―29 |
COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach |
Soha R Abd El Hadi, Esmat E Zien El-Deen, Mostafa M Bahaa, Abdelfattah A Sadakah, Heba A Yassin |
| 20 |
[GO] |
2021―May―02 |
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure |
Osama Badary, Marwa S Hamza, Rajiv Tikamdas |
| 21 |
[GO] |
2021―Mar―28 |
Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19 |
Chenghai Li, Hua Zhao, Linna Cheng, Bin Wang |
| 22 |
[GO] |
2021―Mar―10 |
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model |
Acharya Balkrishna, Subarna Pokhrel, Hoshiyar Singh, Monali Joshi, Vallabh Prakash Mulay, Swati Haldar, Anurag Varshney |
| 23 |
[GO] |
2021―Mar―03 |
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic |
Shenqi Zhang, Chengbin Wang, Lei Shi, Qingyun Xue |
| 24 |
[GO] |
2020―Dec―30 |
Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review |
Yahdiana Harahap, Rasmina Diptasaadya, Denni Joko Purwanto |
| 25 |
[GO] |
2020―Nov―18 |
COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis |
Bin Wang, Junkai Lai, Xiaoyan Yan, Feifei Jin, Bin Yi, Caixia An, Yuanxiao Li, Chen Yao |
| 26 |
[GO] |
2020―Nov―17 |
Repurposing Anti-Cancer Drugs for COVID-19 Treatment |
Nicholas Borcherding, Yogesh Jethava, Praveen Vikas |
| 27 |
[GO] |
2020―Sep―29 |
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19 |
Chenghai Li, Hua Zhao, Bin Wang |
| 28 |
[GO] |
2020―Sep―17 |
Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19 |
Weilong Zhang, Yinghua Lv, Juan Yang, Yunhui Chen, Yingchun He, Jihan Huang |
| 29 |
[GO] |
2020―Aug―20 |
A Single Large Dose of Vitamin D Could be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment |
Guoqiang Liu, Tianpei Hong, Jin Yang |
| 30 |
[GO] |
2020―Aug―05 |
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19 |
Seyed MohammadReza Hashemian, Tayebeh Farhadi, Ali Akbar Velayati |
| 31 |
[GO] |
2020―Jul―27 |
Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients |
Lu Li, Xiaojuan Wang, Rongrong Wang, Yunzhen Hu, Saiping Jiang, Xiaoyang Lu |
| 32 |
[GO] |
2020―Jul―05 |
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19 |
Amin Sedokani, Sadegh Feizollahzadeh |
| 33 |
[GO] |
2020―May―28 |
Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov |
Jihan Huang, Yingchun He, Qianmin Su, Juan Yang |
